SCHEMBL30137686

SCHEMBL30137686

COc1c(OCc2ccccc2)ccc2c1N=C(NC(=O)c1cccnc1)N1CCN=C21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.45
LRRK2 Q5S007 7/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 2/20 0.42
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
MAPT P10636 2/20 0.40
SGMS2 Q8NHU3 1/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1655443 1.00 RAB9A (0.45) RAB9ALRRK2LMNAHTTCYP11B1
SCHEMBL2259993 0.91 LRRK2 (0.37) RAB9ALRRK2LMNAHTTMAPT
SCHEMBL83685 0.89 MAPT (0.46) LMNAMAPTALDH1A1POLBKDM4E
SCHEMBL19328940 0.89 CSNK2A2 (0.37) RAB9ALRRK2ALDH1A1KDM4EMEN1
SCHEMBL1301071 0.88 MAPT (0.38) MAPTALDH1A1POLBKDM4EGAA
SCHEMBL6730444 0.88 MAPT (0.39) MAPTALDH1A1POLBKDM4EGAA
SCHEMBL1497638 0.88 MAPT (0.39) MAPTALDH1A1POLBKDM4EGAA
SCHEMBL1658265 0.87 MAPT (0.38) MAPTALDH1A1POLBKDM4EGAA
SCHEMBL12064247 0.87 MAPT (0.38) MAPTALDH1A1POLBKDM4EGAA
SCHEMBL3677899 0.87 GAA (0.41) LMNAMAPTALDH1A1MEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101631464-B 2,3-dihydroimidazo [1,2-c ] quinazoline substituted derivatives for the treatment of hyperproliferative diseases and angiogenesis-related diseases 拜耳知识产权有限责任公司 2022-12-06 CN disclosed